T0	Limitation 32862 32867	While
T1	Limitation 33144 33147	Our
T2	Limitation 37202 37205	The
T3	Limitation 38181 38183	We
T4	Limitation 38366 38379	Additionally,
T5	UnderpoweredStudy 33098 33142	the study was not powered for these analyses
T6	DiagnosticCriteria 33144 33209	Our patients presented relatively late after the onset of illness
T7	DiagnosticCriteria 37202 37246	The heterogeneous population characteristics
T8	UnderpoweredStudy 38288 38305	power was limited
T9	SampleSize 38241 38281	subgroup analyses involved small numbers
T10	ActivePlacebo 38383 38434	all patients were randomised to an active treatment
T11	Setting 37248 37287	geographical differences in recruitment
T12	DiagnosticCriteria 37401 37446	the variety of infecting viruses in our trial
T13	MultipleTesting 38310 38364	some significant results could have resulted by chance
T14	Limitation 37871 37873	We
T15	Population 37871 37898	We did not have many adults
T16	Limitation 38019 38021	We
T17	Generalization 38019 38179	We would caution the extension of our results to, for example, morbidly obese adults with severe influenza and those who could have underlying chronic illnesses
